Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Global

Global

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cryptocurrency
  • Equities
  • Global
  • Markets
  • News

Bitcoin Transaction Investigation By DOJ Addressed By Block CEO Jack Dorsey: ‘We Take Compliance Seriously’

By Kaustubh Bagalkote
May 2, 11:30 PM
Block Inc. (NYSE:SQ) CEO Jack Dorsey addressed a potential Department of Justice investigation during the company’s first-quarter earnings call on Thursday.

BTC

Read More
4 minute read
  • Biotech
  • Contracts
  • General
  • Global
  • News

ImmunityBio, Serum Institute Of India Agree On An Exclusive Arrangement For Global Supply Of Bacillus Calmette-Guerin Across All Cancer Types

By Benzinga Newsdesk
May 2, 4:45 PM
Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio's recently approved treatment for non-muscle invasive bladder cancer (NMIBC)Serum Institute of India

IBRX

Read More
2 minute read
  • Earnings
  • Global
  • Movers
  • News
  • Tech
  • Top Stories

Thomson Reuters Triumphs in Q1 Backed by AI Product Roadmap and Strategic Acquisitions

By Anusuya Lahiri
May 2, 1:31 PM
Thomson Reuters Corp reported Q1 2024 revenue growth of 8%, beating analyst consensus, with adjusted EPS of $1.11. The stock gained, driven by 9% organic revenue growth. CEO is confident in their AI product roadmap. Outlook is $7.24-$7.27 billion. Stock up 17% in last 12 months.

AIQ

Read More
2 minute read
  • Global
  • News

Semtech Collaborates With Console Connect To Expand Connectivity Coverage In Asia-Pacific

By Benzinga Newsdesk
May 2, 11:32 AM
Semtech Corporation (NASDAQ:SMTC), a high-performance semiconductor, IoT systems, and connectivity service provider, and Console Connect, a leading Network-as-a-Service (NaaS) platform, today jointly announced their

SMTC

Read More
2 minute read
  • Global
  • News

YY Group Announces Strategic Entry Into Vietnam’s Booming Labour Market Within The Hospitality Industry

By Benzinga Newsdesk
May 2, 8:39 AM
YY Group Holding Limited (NASDAQ: YYGH) ("YY Group", "YYGH", or the "Company"), a data and technology-driven company that specializes in creating enterprise intelligent labor matching services and smart cleaning

YYGH

Read More
3 minute read
  • Global
  • News

Canadian Hydropower Producer Upgrades Timing Network With Adtran’s Oscilloquartz Optical Cesium Clock

By Benzinga Newsdesk
May 2, 8:21 AM
Leading utility needed a seamless way to transition from legacy power grid synchronization to ultra-stable PTP timing and resilient PNTOscilloquartz ePRTC+ solution delivers new levels of accuracy and availability with

ADTN

Read More
1 minute read
  • Biotech
  • General
  • Global
  • News

Akoya Biosciences And Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval For KR-HT5 In China To Support Next Generation Pathology Clinical Workflows

By Benzinga Newsdesk
May 2, 8:19 AM
Akoya Biosciences, Inc. (NASDAQ:AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company providing molecular diagnostic solutions in China, have jointly announced that KR-HT5, which Akoya

AKYA

Read More
2 minute read
  • Global
  • News

CDT Environmental Technology Investment Holdings Limited Receives Three New Utility Model Patent Allowances From The China National Intellectual Property Administration

By Benzinga Newsdesk
May 2, 8:11 AM
CDT Environmental Technology Investment Holdings Limited (NASDAQ:CDTG) ("CDT"), a leading provider of waste treatment systems and services throughout China, announces the granting of three patents from the China National

CDTG

Read More
2 minute read
  • Equities
  • Global
  • Health Care
  • Markets
  • News

Demand Soars For Novo Nordisk’s Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition

By Benzinga Neuro
May 2, 5:48 AM
The Danish pharmaceutical company is now shipping more introductory doses of Wegovy to the U.S., as it grapples with supply constraints and competition from Eli Lilly.

CTLT

Read More
2 minute read
  • Analyst Color
  • Cryptocurrency
  • Global
  • Markets
  • News

Is Bitcoin’s Fall Over? Top Crypto Analyst Says ‘Altcoins Are Going To Take Over Until…’

By Benzinga Neuro
May 2, 4:55 AM
Popular crypto analyst Michaël van de Poppe has projected a prolonged recovery period for Bitcoin (CRYPTO: BTC) while anticipating a surge in altcoin performance.

BTC

Posts pagination

Previous 1 … 39 40 41 … 441 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service